Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Neurostatus-UHB is a Swiss healthcare and clinical trial services company focused on standardized neurological assessment in multiple sclerosis and related neuro-immunological diseases. Its core offering is the Neurostatus-Expanded Disability Status Scale (Neurostatus-EDSS), together with digital and training products such as Neurostatus-eEDSS and the Neurostatus-eTest used to certify raters and improve data quality in clinical studies. The company supports global phase II and III randomized controlled trials, academic studies, and clinical research groups with licensing, training, certification, and scoring tools. Neurostatus-UHB appears to operate as a specialized assessment and outcomes platform rather than a therapeutic drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Neurostatus-UHB.